Opko Health, Inc. Granted Patent from European Patent Office For Lagova
6/27/2014 10:22:05 AM
MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK), a multinational biopharmaceutical and diagnostics company, today announced that the European Patent Office granted OPKO a patent covering the company’s long-acting CTP-enhanced human growth hormone product (Lagova), including composition of matter and associated methods.
Help employers find you! Check out all the jobs and post your resume.
comments powered by